Isentress Clinical Trials Isentress RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection
Condition:   Hiv Interventions:   Drug: Raltegravir 400Mg Tab;   Drug: Lamivudine 150Mg Tablet Sponsor:   Guy's and St Thomas' NHS Foundation Trust Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2017 Category: Research Source Type: clinical trials